Our in vitro effects advise that EAM-2201 needs to be examined regarding probable in vivo pharmacokinetic drug–drug interactions because of time-dependent inhibition of CYP2C8, CYP2C9, CYP2C19 and CYP3A4 activities and aggressive inhibition of UGT1A3 activity. Effect from the novel synthetic cannabinoids AKB48 and 5F-AKB48 on “tetrad”, sensorimotor, neurological and neurochemical https://am220175308.canariblogs.com/detailed-notes-on-am-2201-uk-46320717